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Abstract— This paper describes the experimental set up of a 
system composed by a set of wearable sensors devices for the 
recording of the motion signals and software algorithms for the 
signal analysis. This system is able to automatically detect and 
assess the severity of bradykinesia, tremor, dyskinesia and 
akinesia motor symptoms. Based on the assessment of the 
akinesia, the ON-OFF status of the patient is determined for each 
moment. The assessment performed through the automatic 
evaluation of the akinesia is compared with the status reported by 
the patients in their diaries. Preliminary results with a total 
recording period of 32 hours with two PD patients are presented, 
where a good correspondence (88.2 +/- 3.7 %) was observed. Best 
(93.7%) and worst (87%) correlation results are illustrated, 
together with the analysis of the automatic assessment of the 
akinesia symptom leading to the status determination. The results 
obtained are promising, and if confirmed with further data, this 
automatic assessment of PD motor symptoms will lead to a better 
adjustment of medication dosages and timing, cost savings and an 
improved quality of life of the patients. 
I. INTRODUCTION 
PARKINSON'S disease (PD) is a progressive neurodegenerative disorder associated with motor 
dysfunction characterized by bradykinesia, resting tremor, 
muscle rigidity, and postural instability [1]. 
Current therapies are effective in managing Parkinsonian 
symptoms in the early stages of the disease. However, in late 
stage PD, patients develop motor complications, such as the 
abrupt loss of the efficacy of medications at the end of a 
dosing interval, involuntary hyperkinetic movements referred 
to as dyskinesia, gait dysfunctions such as festination, start 
hesitation and freezing of gait [2]. These impairments result in 
a highest propensity to falls, as well as a reduced capacity to 
walk [3], and lead to progressive functional restraints. Motor 
fluctuations during the day are also affected by medication 
timing, other drugs not related to PD, meals or sleeping 
deficiency [4]. 
Currently, motor assessment in PD is mainly based on 
historical information, home diaries and neurological 
examination during visits to the clinic. These methods clearly 
suffer from many limitations: data can be highly subjective, 
they depend on patient's memory that could be affected by the 
disease, patients could unconsciously exaggerate or attenuate 
symptoms' severity, and there could be a lack of 
comprehension because of a poor capacity to understand 
medical terminology or insufficient experience of the 
physician in the field. Moreover, most of the patients may not 
be aware of mild tremor or dyskinesia. 
In an attempt to solve these problems and to find more 
objective assessments, several scales, based on impairment 
[5] [6] [7], disability [8] [9] and quality of life [10], have been 
designed and used, but all them suffer from limits: intra and 
inter-observer inconsistencies and subjectivity issues related to 
historical information. Moreover, the pattern and severity of 
PD symptoms may vary considerably during the day, while 
clinical rating scales only provide moment-to-moment 
assessments; and finally, measurements of motor functions 
made in the clinic may not accurately reflect the actual 
functional disability experienced by the patients in their daily 
life. In addition to rating scales, akinesia tremor, rigidity and 
gait and postural stability are sometimes evaluated by means of 
motor performance test, but they are limited to the setting of 
the clinic or laboratory. Direct observation by a PD specialist, 
as an alternative to historical information revision, results 
impractical because motor fluctuations cover the time of 
several hours between medication dosages. 
This paper describes an integrated platform to enable access 
to data gathered using wearable sensors via a web application. 
PERFORM project aims at testing an innovative and reliable 
tool, for monitoring PD patients at home. PERFORM wearable 
system could objectively monitor and quantify disease 
fluctuation across the day, in function of meals, drugs and 
sleep. The clinician can remotely monitor the overall status of 
the patients, adjust medication schedules and personalize 
treatment. Collecting data in the home setting using this system 
has the potential to allow clinicians to improve quality of care 
in patients with PD, also reducing its costs. 
II. STUDY DESCRIPTION 
A. System for data collection 
An integrated system, composed by a set of wearable sensors 
devices for the recording of the motion signals and software 
algorithms for the signal analysis, has been used in order to 
constantly acquire motor signals of the patients. 
The hardware is formed by a set of four tri-axial 
accelerometers positioned at each patient limb used to record 
signals from legs and harms; a belt sensor, composed by an 
accelerometer and a gyroscope, used to record body movement 
accelerations and angular rate; and a data logger used to 
receive and store all recorded signals in a SD card. All sensors 
transmit data using Zigbee protocol to the logger device, with 
62.5 Hz sampling rate. 
Data acquired are pre-processed by advanced knowledge 
processing methods, integrated by fusion algorithms to allow 
health professionals to remotely monitor the overall status of 
the patients, adjust medication schedules and personalize 
treatment. Adjustment of treatment occurs through the 
capability of keeping track of the timing and doses of the 
medication and meals that the patient is taking [12]. 
B. Experimental Setup 
The objective of the exposed experimental is assessing the 
motor status of patients with Parkinson's disease in an 
unsupervised environment, with the aim of obtaining an 
objective assessment of motor performance in relation to the 
consumption of drugs. 
In order to achieve this goal, the patients were asked to wear 
the sensors at home during a week. The schedule of the 
recording sessions was programmed by a technician directly at 
the patient's house, discussing with him/her the most 
appropriate timing. The patient was requested to wear the 
devices 10 minutes before the start of the pre-scheduled 
monitoring session, then he/she was free to do his/her 
everyday activities. During the day the patient had to introduce 
the information about the medication and meal intake, using 
the developed User Interface. At the end of the day the patient 
had to connect the data logger to the PC, where the data 
downloading and signal processing started automatically. 
C. Patients data 
Patients fulfilling the following criteria were eligible for the 
study: diagnosis of Parkinson's disease, aged between 40-75 
years old, ambulatory and capable of complying with study 
requirements, receiving stable dopaminergic treatment, 
experiencing motor fluctuations and presence of a responsible 
caregiver who could cooperate with the patient and his/her 
neurology specialist. The exclusion criteria for this study were 
suffering from dementia, psychosis (simple visual 
hallucinations excluded) or a significant systemic disease (such 
as: cancer, hepatic or kidney dysfunction, etc.). 
During the trials, 25 PD patients were selected (8 women and 
17 men) with an age ranging from 41 and 79 years old (mean 
60.9± 9.0 years). 
III. RESULTS 
The aim of the experiment was to test the behavior of the 
developed system in an uncontrolled environment. In order to 
evaluate and validate the general architecture, results of the 
automatic assessment are compared with the results of the 
patient diary. A proof of concept of the system with 2 patients, 
including the best and the worst case is presented. 
Furthermore, the result of the compliance and level of comfort 
evaluation of the prototype system is illustrated, including the 
results of the 25 PD patients tested in Modena, Italy. 
A. ON/OFF Evaluation. Methodology and assessment. 
During the trial phase all patients filled a diary during two 
consecutive days. Patients were asked to indicate their motor 
condition every half an hour during the day, using a 3 level 
classification (OFF, ON without dyskinesia and ON with 
dyskinesia). 
It was then performed a correlation analysis of the daily 
diary classification with the output of the system ON/OFF 
evaluation based on the results of the classifiers developed for 
the recognition of each symptom . The aim was to evaluate the 
capability of system to automatically discriminate ON/OFF 
conditions. 
This paper present the results of the test carried out for two 
different patients during the last phase of PERFORM project 
trials in Modena, Italy. Considering the time frame during 
which the data were comparable to patient diary (2 daily 
sessions of 4 hours for 2 patients during 2 days, i.e. total of 32 
hours) a good correspondence (88.2 +/- 3.7 %) between 
patient's diary and ON/OFF phases identified by the system 
was observed. Hereinafter the best and the worst case are 
presented, together with the explanation of the results 
compared for the particular case of the automatic assessment 
of the Akinesia [12]. 
Fig. 1 shows the best case results. The black line describes 
the general ON/OFF trend as result of the information 
introduced by patient in the diary. The gray line indicates the 
ON/OFF evaluation based on the automatic assessment of the 
PD symptom by the system under evaluation. The correlation 
between the patient's diary and the automatic assessment 
reaches 93.7%. 
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Fig. 1 ON/OFF results comparison of the diary and the overall status 
assessment using the automatic assessment of the PERFORM system - Best 
Case. 
A small delay around the transition phases ON/OFF (Fig. 1) 
is observed. In fact, since the diaries were filled every 30 
minutes, they produced a relevant degree of data roughness. 
On the other hand, the system for the automatic assessment 
registered real-time signals, allowing an exact description of 
the motor status. 
From a therapeutic point of view even a delay of 10-15 
minutes, though seemingly short, may be crucial in patients 
with motor fluctuation. In fact, it is known that taking a new L-
Dopa medication when a previous dose effect has not been 
finished (still in ON condition) cause a more stable and a good 
global response with lower dosage of the drug. Moreover, if L-
dopa is taken when the effect of the previous dose has 
completely extinguished (OFF-condition) the clinical response 
is unpredictable (absent, delayed and intermittent). Therefore, 
having an accurate ON/OFF indicator system can help 
clinicians to plan a more effective therapeutic schedule. 
One of the most characteristic PD symptoms is the Akinesia 
[12], that describes the general daily evolution of the 
syndrome, computing the energy produced along the day. Fig. 
2 shows the evolution of akinesia corresponding to the result 
of the comparison showed in Fig. 1. In this case the ON and 
OFF transition can be easily detected using the output of the 
automatic assessment of the system thanks to the data collected 
in both phases. 
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Fig. 2 Akinesia level corresponding to the best case of ON/OFF comparison. 
Fig. 3 shows the worst case results. The correlation between 
the patient's diary and the automatic assessment reaches 87%, 
but the OFF phase detected by the automatic assessment of the 
PD symptom does not match the OFF phase indicated by the 
patient. 
This mismatching can be caused by different reasons. 
Analysing Fig. 4 the patient, during the second part of the 
recording, has pointed as OFF and ON two conditions not 
particularly different from each other. Considering the 
analyses based on the quantitative data obtained from the 
PERFORM system, it is evident that these two conditions are 
more likely a partial OFF status followed by a partial ON 
status. 
The advantage of a better definition of the motor status 
results in a more appropriate adjustment of the drug dosage. 
Moreover, during the OFF phase indicate by the patients, a 
block, and a corresponding lack of data, is detected with the 
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Fig. 3 ON/OFF results comparison of the diary and the overall status 
assessment using the automatic assessment of the PERFORM system - Worst 
Case. 
In particular, in this specific patient, in view of the system 
assessment, it was decided to increase by 25 mgs (from 100 to 
125) the L-dopa dose taken at 5 pm. As a result, in the next 
week patient reported a disappearance of that OFF phase. 
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Fig. 4 Akinesia level corresponding to the worst case of ON/OFF comparison 
Furthermore, the analysis of the quantitative data provided 
correlations with activities indicated by patient (walk, rest, 
hand-activities) even related with the specific patient job. In 
this case the subject is a dentist and he reported, at the end of 
the morning, difficulties in performing a tooth extraction 
which caused embarrassment in front of his patient. 
B. Compliance and level of comfort 
An evaluation regarding the wearability of the system was 
performed at the end of every trial session, in order to produce 
a global evaluation about level of comfort. All the evaluations 
were based on a scale composed of five items, with different 
evaluation levels (poor, insufficient, sufficient, good and 
optimal). 
Generally users did not face any problem using the system, 
placing the overall compliance level between good and 
optimal. As showed in Fig. 5, 16 of 25 subjects (65%) reported 
that the system was comfortable (good/optimal) and that it 
could be used for monitoring clinical state outside of 
experimental conditions. Four patients reported that the system 
was not comfortable mainly due to the dimension and weight 
of the wearable devices and the frequent loss of connection. 
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Fig. 5 Comfort evaluation results obtained in the last trials phase. 
IV. CONCLUSION 
An innovative wearable system for the remote monitoring 
and evaluation of PD motor symptoms has been described. 
The results of the assessment performed by a specialist have 
been compared with diaries and system data for two patients. 
They have been presented as proof of concept of the system 
clinical value for the discrimination of ON and OFF states. In 
addition, an evaluation regarding the comfort of the system has 
been performed with 25 users, suggesting that it is generally 
regarded as usable. 
A. Impact 
Better control of the disease symptoms will have a 
synergistic positive effect on the psychosocial and physical 
functioning of the patients. Therefore patients are empowered 
to play a full role in society by living independently, working, 
participating in social activities and enjoying life. 
B. Medical and Innovation utility 
This system is expected to provide work efficiency to 
healthcare professionals (e.g. through the utilisation of multi-
parametric information fusion and consistent decision support 
tools, remote monitoring, reduction of patient visits health 
assessment and treatment adjustment). In addition, it will allow 
the advance in medical research through the exploitation of the 
vast pool of monitored parameters and the generated statistical 
data for the production of new diagnostic models and 
protocols. Although the application domain is the Parkinson's 
disease, there seems to be a great potential and easy future 
exploitation in other target groups such as other 
neurodegenerative diseases with similar motor and mental 
disabilities. 
C. Low Cost System for chronicle disease 
This system will achieve cost and effort savings related to 
frequent visits to hospitals for assessment and treatment 
modification, considering that most PD patients are elderly, 
present mobility impairments and may live in rural areas. In 
addition, an optimal diagnosis and monitoring is expected to 
decrease the expenses in drugs, and therefore reduce the costs 
associated to the disease follow up. 
The results presented in this paper are promising, even if 
more work will be done in order to give a complete clinical 
validation. In particular, future work will be focused on the 
improvement of the wearable system, including mobile 
technology, making it more portable and usable. Moreover, 
future improvement will be dealing with the "lack of data" 
period. For example, a mobile application associated to the 
system, will be able to request to the patient about the actual 
ON-OFF state during rest periods. 
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